Opexa Therapeutics, Inc.·4

Oct 4, 8:02 AM ET

Opexa Therapeutics, Inc. 4

4 · Opexa Therapeutics, Inc. · Filed Oct 4, 2016

Insider Transaction Report

Form 4
Period: 2016-09-30
Transactions
  • Award

    Common Stock

    2016-09-30+6,45529,989 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    129,676
Footnotes (1)
  • [F1]Held by Alkek and Williams Ventures, Ltd. ("Ventures"). Chaswil, Ltd. ("Chaswil") is the investment manager of Ventures and holds voting power and investment power with respect to the Issuer securities held by Ventures. Mr. Seaman is a registered principal of Chaswil and has shared voting power and or investment power with respect to the Issuer securities held by Ventures. Mr. Seaman disclaims beneficial ownership of the shares held by Ventures except to the extent of any pecuniary interest therein.

Documents

1 file
  • 4
    issuerdirect_section16.xmlPrimary

    PRIMARY DOCUMENT